Proehl Gerald T - Jun 9, 2022 Form 4 Insider Report for TENAX THERAPEUTICS, INC. (TENX)

Role
Director
Signature
/s/ S. Halle Vakani, as Attorney-in-Fact
Stock symbol
TENX
Transactions as of
Jun 9, 2022
Transactions value $
$0
Form type
4
Date filed
6/10/2022, 09:28 PM
Previous filing
Jan 5, 2022
Next filing
Jan 5, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding TENX Common Stock 1.5K Jun 9, 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TENX Stock Option (right to buy) Award $0 +5K $0.00 5K Jun 9, 2022 Common Stock 5K $0.62 Direct
holding TENX Stock Option (right to buy) 500 Jun 9, 2022 Common Stock 500 $6.23 Direct
holding TENX Stock Option (right to buy) 500 Jun 9, 2022 Common Stock 500 $0.66 Direct
holding TENX Stock Option (right to buy) 5K Jun 9, 2022 Common Stock 5K $2.00 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.